UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$566.03 USD
-5.31 (-0.93%)
Updated Oct 17, 2024 04:00 PM ET
Pre-Market: $563.30 -2.73 (-0.48%) 9:26 AM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$566.03 USD
-5.31 (-0.93%)
Updated Oct 17, 2024 04:00 PM ET
Pre-Market: $563.30 -2.73 (-0.48%) 9:26 AM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
UnitedHealth Group (UNH) Stock Moves -1.51%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $272.38, moving -1.51% from the previous trading session.
The Zacks Analyst Blog Highlights: UnitedHealth Group, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth Group, Anthem and Humana
Stock Market News For Nov 8, 2018
by Zacks Equity Research
Markets closed sharply higher on Wednesday following midterm election results that witnessed Democrats taking control of the House, while Republicans managing to hold majority in the Senate.
UnitedHealth (UNH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
UnitedHealth (UNH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Midterm Elections Put These Health Insurers in Focus
by Sapna Bagaria
U.S. Health Insurers should gain from Medicaid Expansion that might be bought by Democratic control in the House of Representatives.
Humana's (HUM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Humana Inc.'s (HUM) Q3 earnings gain from Medicare Advantage enrollment, operational efficiency and lower impatient medical utilization
Zacks.com highlights: BJ's Restaurants, CBRE Group, Dave & Buster's Entertainment, UnitedHealth Group and O'Reilly Automotive
by Zacks Equity Research
Zacks.com highlights: BJ's Restaurants, CBRE Group, Dave & Buster's Entertainment, UnitedHealth Group and O'Reilly Automotive
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $263.54 in the latest trading session, marking a +0.97% move from the prior day.
Tenet Healthcare's (THC) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings benefit on the back of USPI and Conifer Segments.
5 Stocks That Stand Out on Attractive Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.
Ensign Group's (ENSG) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results gain from solid segmental performances.
Teladoc (TDOC) Q3 Loss Lower Than Estimates, Revenues Beat
by Zacks Equity Research
Teladoc's (TDOC) Q3 results show lower losses, revenues gain from increase in membership and patient visits.
Dow Recovers More Than 900 Points in 3 Days: 5 Top Picks
by Nalak Das
The meltdown of the 30-stock Dow was transitory in nature and can provide a good entry point for investors.
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Cigna (CI) Q3 Earnings & Revenues Beat, Guidance Up
by Zacks Equity Research
Cigna (CI) Q3 earnings gain on revenue and membership growth.
WellCare Health (WCG) Q3 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
WellCare Health's (WCG) Q3 earnings beat estimates on the back of Meridian buyout, organic growth and higher membership.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings top on the back of a strong operating performance.
HCA Healthcare's (HCA) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings improve on the back of rising admissions.
Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases
by Zacks Equity Research
Aetna (AET) earnings grow on revenue and membership gains.
The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth, AT&T and Intel
UnitedHealth Group (UNH) Stock Moves -0.6%: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $256.62, marking a -0.6% move from the previous day.
Top Analyst Reports for Johnson & Johnson, UnitedHealth, AT&T & Intel
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Johnson & Johnson (JNJ), UnitedHealth (UNH), AT&T (T) and Intel (INTC).
Universal Health (UHS) Q3 Earnings Beat, 2018 View Narrows
by Zacks Equity Research
Universal Health's (UHS) Q3 benefits from an improved performance at both its segments.
Is UnitedHealth Group (UNH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?